Supradent Drugs Limited

Founded in 2008 and headquartered in Tamil Nadu, India.

2008 | Dharmapuri, Tamil Nadu (India) | Active
Last Updated:

Supradent Drugs Profile

Key Indicators

  • Authorised Capital ₹ 2.50 M
  • Paid Up Capital ₹ 1.07 M
  • Company Age 16 Year, 8 Months
  • Last Filing with ROC 31 Mar 2012
  • Open Charges ₹ 3.00 M

About Supradent Drugs

Supradent Drugs Limited (SDL) is a Public Limited Indian Non-Government Company incorporated in India on 23 June 2008 and has a history of 16 years and eight months. Its registered office is in Dharmapuri, Tamil Nadu, India.

The Company is engaged in the Chemicals Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2012. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.07 M.

The company currently has active open charges totaling ₹3.00 M.

Venkatesan Goppi, Nallakannu Prabakar, and Radhakrishnan Murali serve as directors at the Company.

Company Details

  • Location

    Dharmapuri, Tamil Nadu, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24230TZ2008PLC017228

  • Company No.

    017228

  • Company Classification

    Public Limited Indian Non-Government Company

  • Incorporation Date

    23 Jun 2008

  • Date of AGM

    29 Sep 2012

  • Date of Balance Sheet

    31 Mar 2012

  • Listing Status

    Unlisted

  • ROC Code

    Roc Coimbatore

Industry

Chemicals
Pharmaceuticals
Company report

Supradent Drugs Limited

Explore comprehensive data for Supradent Drugs Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Supradent Drugs?

Executive Team (1)

NameDesignationAppointment DateStatus
Venkatesan Goppi Country flag representing In Managing Director23-Jun-2008Current

Board Members (2)

NameDesignationAppointment DateStatus
Nallakannu Prabakar Country flag representing In Director 23-Jun-2008Current
Radhakrishnan Murali Country flag representing In Director 01-Jun-2009Current

Financial Performance of Supradent Drugs.

Enhance accessibility to Supradent Drugs's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Supradent Drugs revenue growth over time
Supradent Drugs profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
Revenue from Operations
Total Assets
Profit or Loss
Net Worth
EBITDA

What is the Ownership and Shareholding Structure of Supradent Drugs?

Unlock access to Supradent Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹3.00 M

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

  • Indian Bank : 0.30 Cr

Latest Charge Details

DateLenderAmountStatus
14 Oct 2011Indian Bank₹3.00 MOpen

How Many Employees Work at Supradent Drugs?

Unlock and access historical data on people associated with Supradent Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Supradent Drugs Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Supradent Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Supradent Drugs's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Supradent Drugs

Recent activity within the organization

  • Annual General Meeting

    Supradent Drugs Limited last Annual general meeting of members was held on 29 Sep 2012 as per latest MCA records.

  • Balance Sheet

    Supradent Drugs Limited has filed its annual Financial statements for the year ended 31 Mar 2012 with Roc Coimbatore.

  • Charges

    A charge with Indian Bank amounted to Rs. 3.00 M with Charge ID 10317206 was registered on 14 Oct 2011.

  • Director Appointment

    Radhakrishnan Venu Murali was appointed as a Director was appointed as a Director on 01 Jun 2009 & has been associated with this company since 15 years 9 months .

  • Director Appointment

    Venkatesan Goppi was appointed as a Managing Director was appointed as a Managing Director on 23 Jun 2008 & has been associated with this company since 16 years 8 months .

  • Director Appointment

    Nallakannu Baskara Prabakar was appointed as a Director was appointed as a Director on 23 Jun 2008 & has been associated with this company since 16 years 8 months .

Frequently asked questions

  • What is the Incorporation or founding date of Supradent Drugs Limited?

    Supradent Drugs Limited was incorporated on 23 Jun 2008.

  • What is authorized share capital and paid-up capital of Supradent Drugs Limited?

    The authorized share capital of Supradent Drugs Limited is ₹ 2.50 M and paid-up capital is ₹ 1.07 M.

  • Who are the current board members & directors of Supradent Drugs Limited?

    Currently 3 directors are associated with Supradent Drugs Limited.

    • Venkatesan Goppi
    • Nallakannu Baskara Prabakar
    • Radhakrishnan Venu Murali
  • What is the registered address of Supradent Drugs Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Supradent Drugs Limited is 15/3 South Narasimachary Street India, Dharmapuri, Tamil Nadu, 636701.

  • What is the corporate identification number (CIN) and company number of Supradent Drugs Limited?

    The corporate identification number (CIN) of Supradent Drugs Limited is U24230TZ2008PLC017228 and the company number is 017228 as per Ministry of Corporate Affairs (MCA).

  • What are the total open charges for Supradent Drugs Limited?

    As per the financial statements for fiscal Year 0, The total open charges for Supradent Drugs Limited amount to ₹ 3.00 M.

  • When was the last Balance Sheet of Supradent Drugs Limited filed with the ROC?

    The most recent Balance Sheet for Supradent Drugs Limited was filed with the ROC on 31 Mar 2012.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed